Salud financiera de hoja de balance de Daito PharmaceuticalLtd
Salud financiera controles de criterios 5/6
Daito PharmaceuticalLtd has a total shareholder equity of ¥52.1B and total debt of ¥12.1B, which brings its debt-to-equity ratio to 23.3%. Its total assets and total liabilities are ¥81.9B and ¥29.8B respectively. Daito PharmaceuticalLtd's EBIT is ¥3.7B making its interest coverage ratio -406.9. It has cash and short-term investments of ¥4.7B.
Información clave
23.3%
Ratio deuda-patrimonio
JP¥12.14b
Deuda
| Ratio de cobertura de intereses | -406.9x |
| Efectivo | JP¥4.69b |
| Patrimonio | JP¥52.08b |
| Total pasivo | JP¥29.85b |
| Activos totales | JP¥81.93b |
Actualizaciones recientes sobre salud financiera
No hay actualizaciones
Análisis de la situación financiera
Pasivos a corto plazo: 4577's short term assets (¥45.8B) exceed its short term liabilities (¥18.8B).
Pasivo a largo plazo: 4577's short term assets (¥45.8B) exceed its long term liabilities (¥11.1B).
Historial y análisis de deuda-patrimonio
Nivel de deuda: 4577's net debt to equity ratio (14.3%) is considered satisfactory.
Reducción de la deuda: 4577's debt to equity ratio has increased from 14% to 23.3% over the past 5 years.
Cobertura de la deuda: 4577's debt is well covered by operating cash flow (42.7%).
Cobertura de intereses: 4577 earns more interest than it pays, so coverage of interest payments is not a concern.